Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128352 | SCV000171946 | benign | not specified | 2013-05-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000727280 | SCV000707191 | uncertain significance | not provided | 2017-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082665 | SCV001004508 | likely benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727280 | SCV001156015 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | SYN1: BP4, BP7, BS2 |
Ambry Genetics | RCV002399505 | SCV002708788 | likely benign | Inborn genetic diseases | 2018-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |